Feb 3CCSS Statement on FDA Cannabinoid Pathway Framework AnnouncementCCSS looks forward to working with Congress and FDA on a science-based approach to regulate non-drug CBD products, protecting consumer safety must be paramount.Click here to view the PDF.
CCSS looks forward to working with Congress and FDA on a science-based approach to regulate non-drug CBD products, protecting consumer safety must be paramount.Click here to view the PDF.